Adverse drug reactions in utero: Perspectives on teratogens and strategies for the future

Clinical Pharmacology and Therapeutics

Volumn 89, Issue 6, 2011, Pages 781-783

  Mitchell, A A ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

ADVERSE DRUG REACTION; BIRTH DEFECT; DIZZINESS; DRUG EXPOSURE; HUMAN; HYPOTENSION; PREGNANCY; PRIORITY JOURNAL; REVIEW; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; DRUG TOXICITY; FEMALE; FORECASTING; HUMANS; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TERATOGENS;

EID: 79956324150     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2011.52     Document Type: Review

References (4)

1. Mitchell, A.A. Studies of Drug-Induced Birth Defects. In Strom B.L.: Pharmacoepidemiology 4th edn (ed. Strom, B.L.) (Wiley, Chichester, UK, 2005).
2. Mitchell, A.A. Systematic identification of drugs that can cause birth defects-a new opportunity. N. Engl. J. Med. 349, 2556-2559 (2003). (Pubitemid 38010084)
3. Schatz, M., Chambers, C.D., Lyons, K.L., Louik, C. & Mitchell, A.A. Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System. Am. J. Obstet. Gynecol.; e-pub ahead of print 17 February 2011.
4. HR 3580 FDA Amendments Act, 2007, Sec 905; D.I.II.Bb.